Pharmaceutical Compositions
    2.
    发明申请
    Pharmaceutical Compositions 审中-公开
    药物组合物

    公开(公告)号:US20080064674A1

    公开(公告)日:2008-03-13

    申请号:US11940046

    申请日:2007-11-14

    IPC分类号: A61K31/56 A61M11/00

    摘要: Disclosed are metered dose inhalers having a metering valve to deliver a dose containing an aerosol suspension formulation, said aerosol suspension formulation comprising: an effective amount of Mometasone Furoate, Formoterol or a combination thereof; a suspension medium selected from the group consisting of 1,1,1,2,3,3,3,-heptafluoropropane, 1,1,1,2-tetrafluoroethane; and a solvent that is ethanol; wherein said formulation contains less than about 500 μg of non-volatile residue as measured by ultraviolet spectroscopy.

    摘要翻译: 公开了具有计量阀以计量含有气溶胶悬浮液制剂的计量剂量吸入器,所述气溶胶悬浮液制剂包含:有效量的糠酸莫米松,福莫特罗或其组合; 选自1,1,1,2,3,3,3, - 七氟丙烷,1,1,1,2-四氟乙烷的悬浮介质; 和乙醇的溶剂; 其中所述制剂含有通过紫外光谱测量的小于约500杯非挥发性残余物。

    Pharmaceutical compositions
    3.
    发明申请
    Pharmaceutical compositions 审中-公开
    药物组合物

    公开(公告)号:US20050136009A1

    公开(公告)日:2005-06-23

    申请号:US10967719

    申请日:2004-10-18

    摘要: Disclosed are metered dose inhalers having a metering valve to deliver a dose containing an aerosol suspension formulation, said aerosol suspension formulation comprising: an effective amount of Mometasone Furoate, Formoterol or a combination thereof; a suspension medium selected from the group consisting of 1,1,1,2,3,3,3,-heptafluoropropane, 1,1,1,2-tetrafluoroethane; and a solvent that is ethanol; wherein said formulation contains less than about 500 μg of non-volatile residue as measured by ultraviolet spectroscopy.

    摘要翻译: 公开了具有计量阀以计量含有气溶胶悬浮液制剂的计量剂量吸入器,所述气溶胶悬浮液制剂包含:有效量的糠酸莫米松,福莫特罗或其组合; 选自1,1,1,2,3,3,3, - 七氟丙烷,1,1,1,2-四氟乙烷的悬浮介质; 和乙醇的溶剂; 其中所述制剂含有通过紫外光谱测量的小于约500杯非挥发性残余物。